Desmoplastic small round cell tumor: an update of current management practices
- PMID: 40254671
- DOI: 10.1186/s43046-025-00276-0
Desmoplastic small round cell tumor: an update of current management practices
Abstract
Background: Desmoplastic small round cell tumor (DSRCT) poses a diagnostic challenge, initiating with imaging techniques like ultrasound, CT, MRI, and PET scans, with CT being the primary choice for abdominal tumor visualization. Despite advances, the absence of a standardized staging system complicates the diagnostic process.
Methods: A comprehensive literature review and search strategy, encompassing databases like PubMed and Cochrane was performed.
Results: Systemic chemotherapy, notably the P6 regimen, is the cornerstone of DSRCT treatment, while other options, including CDK4/6 inhibitors, antibody-drug conjugates, and anlotinib present varying efficacy. A novel chemotherapeutic agent, ONC-201, exhibits promise, inhibiting tumor growth in preclinical models. Surgical management, encompassing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC), reveals improved survival rates, particularly when combined with chemotherapy. Whole abdomen radiotherapy (WART) emerges as a post-chemotherapy treatment option, despite potential complications. A study employing whole abdominopelvic intensity-modulated radiation therapy (WAP-IMRT) suggests reduced radiation toxicity compared to conventional WART. Immunotherapy, targeting receptors such as B7-H3, GD2, EGFR, HER2, tyrosine kinase inhibitors, and androgen receptors is a promising avenue, especially in younger populations, given its favorable long-term effects. Additionally, the inclusion of CCDN1 genomic alterations further informs potential targeted therapies for DSRCT.
Discussion: This comprehensive review provides a current understanding of DSRCT diagnosis and treatment modalities, highlighting the ongoing challenges and promising avenues for future research. The integration of personalized approaches, novel chemotherapeutic agents, and evolving immunotherapy strategies holds the potential to enhance outcomes for individuals with DSRCT.
Keywords: Chemotherapy; Desmoplastic small cell round tumor; HIPEC; Radiation; Surgery.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Ethics approval and consent to participate: Not applicable (no human participants, human data, or human tissue involved). Consent for publication: Consent for publication is not required (no individual person’s data included). Competing interests: The authors declare that they have no competing interests.
Similar articles
-
Reduced toxicity with intensity modulated radiation therapy (IMRT) for desmoplastic small round cell tumor (DSRCT): an update on the whole abdominopelvic radiation therapy (WAP-RT) experience.Int J Radiat Oncol Biol Phys. 2013 Jan 1;85(1):e67-72. doi: 10.1016/j.ijrobp.2012.09.005. Epub 2012 Oct 17. Int J Radiat Oncol Biol Phys. 2013. PMID: 23084475
-
Abdominal desmoplastic small round cell tumor without extraperitoneal metastases: Is there a benefit for HIPEC after macroscopically complete cytoreductive surgery?PLoS One. 2017 Feb 24;12(2):e0171639. doi: 10.1371/journal.pone.0171639. eCollection 2017. PLoS One. 2017. PMID: 28234908 Free PMC article.
-
Whole abdominopelvic intensity-modulated radiation therapy for desmoplastic small round cell tumor after surgery.Int J Radiat Oncol Biol Phys. 2012 May 1;83(1):317-26. doi: 10.1016/j.ijrobp.2011.06.1985. Epub 2011 Nov 19. Int J Radiat Oncol Biol Phys. 2012. PMID: 22104361 Free PMC article.
-
Intra-Abdominal Desmoplastic Small Round Cell Tumor (DSRCT) and the Role of Hyperthermic Intraperitoneal Chemotherapy (HIPEC): A Review.Curr Oncol. 2023 Mar 31;30(4):3951-3963. doi: 10.3390/curroncol30040299. Curr Oncol. 2023. PMID: 37185412 Free PMC article. Review.
-
Cytoreductive Surgery Followed by Hyperthermic Intraperitoneal Chemotherapy in DSRCT: Progress and Pitfalls.Curr Oncol Rep. 2015 Aug;17(8):38. doi: 10.1007/s11912-015-0461-1. Curr Oncol Rep. 2015. PMID: 26092407 Review.
References
-
- Mello CA, Campos FAB, Santos TG, Silva MLG, Torrezan GT, Costa FD, et al. Desmoplastic small round cell tumor: a review of main molecular abnormalities and emerging therapy. Cancers (Basel). 2021;13(3):498. https://doi.org/10.3390/cancers13030498 . Published 2021 Jan 28. - DOI - PubMed - PMC
-
- de Marcellus C, Sarnacki S, Pierron G, Ranchère-Vince D, Scalabre A, Bolle S, et al. Les tumeurs desmoplastiques à petites cellules rondes de l’enfant, de l’adolescent et du jeune adulte [Desmoplastic small round cell tumor in children, adolescents and young adults]. Bull Cancer. 2018;105(5):523–36. https://doi.org/10.1016/j.bulcan.2018.01.014 . - DOI - PubMed
-
- Jayakrishnan T, Moll R, Sandhu A, Sanguino A, Kaur G, Mao S. Desmoplastic small round-cell tumor: retrospective review of institutional data and literature review. Anticancer Res. 2021;41(8):3859–66. https://doi.org/10.21873/anticanres.15179 . - DOI - PubMed
-
- Sun M, Shao M, Jiang X, Yin T, Wang Q, Zhao L, et al. Desmoplastic small round cell tumor of the head and neck: a clinicopathological, immunohistochemical and molecular analysis of three cases with literature review. Int J Surg Pathol. 2023;31(5):742–50. https://doi.org/10.1177/10668969221117989 . - DOI - PubMed
-
- Kushner BH, LaQuaglia MP, Wollner N, Lindsley KL, Ghavimi F, Merchant TE, et al. Desmoplastic small round-cell tumor: prolonged progression-free survival with aggressive multimodality therapy. J Clin Oncol. 1996;14(5):1526–31. https://doi.org/10.1200/JCO.1996.14.5.1526 . - DOI - PubMed
Publication types
MeSH terms
LinkOut - more resources
Research Materials
Miscellaneous